Skip to content

Hole Ousia

being and becoming in the world

  • HOME
  • ABOUT ME
    • Courage to care
    • Rebel antiquary
    • Deeside Tales
    • Mavisbank: Repeats its love
    • Peter’s poems
    • Two cultures
  • Hole Ousia: OVERVIEW
  • MY FILMS
    • Films by category
  • CONTACT
  • MEDICINE
    • British Medical Journal
    • Psychiatry
      • Antidepressants
      • Paid opinion leaders
      • Royal College of Psychiatrists
        • Continuing Medical Education
        • Pharmaceutical Industry
        • International Congress
        • British Association of Psychopharmacology
        • Core values for psychiatrists
    • Patient safety
      • Cumberlege review
      • Sunshine legislation
HomeAbout meCourage to CareTimely diagnosis of dementiaThe ‘Edinburgh Consensus’Anti-amyloid immunotherapies: low benefit/risk ratioEstimating the true value: Aducanumab and Donanemab for Early Alzheimer Disease

Estimating the true value: Aducanumab and Donanemab for Early Alzheimer Disease

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
Peter Scott-Gordon: gardener, artist, retired doctor: peter@holeousia.com
Powered by WordPress.com.
Scroll Up